Skip to Content
  • Previous Rank583
  • Revenues ($M)$4,860
  • Revenue Percent Change18.4%
  • Profits ($M)$895.5
  • Profits Percent Change40.8%
  • Assets ($M)$6,974
  • Employees5,400
  • Market Value — as of March 31, 2017 ($M)$41,107
Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
Leonard S. Schleifer
CEO Title
President, Chief Executive Officer & Director
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
Tarrytown, NY
Websitehttp://www.regeneron.com
Years on Fortune 500 List-
Employees5,400

Regeneron Pharmaceuticals Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$4,86018.4%
Profits ($M)$895.540.8%
Assets ($M)$6,974-
Total Stockholder Equity ($M)$4,449-
Market Value — as of March 31, 2017 ($M)$41,107-

Profit Ratios

Profit as % of Revenues18.4%
Profits as % of Assets12.8%
Profits as % of Stockholder Equity20.1%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)7.7
EPS % Change (from 2015)39.5%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2016)-32.4%
Total Return to Investors (5 year, annualized)46%
Total Return to Investors (10 year, annualized)33.7%